Indication

Pellagra

Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production. Read more about Pellagra

25 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Pellagra therapies.

Showing 19–25 of 25 drugs

NIACINAMIDE

NIACIN/NIACINAMIDE (VITAMIN B-3)·NIACIN DEFICIENCY·+1
RUGBY

NIACINAMIDE

NIACIN DEFICIENCY·+1
GSK Consumer Healthcare

NIACINAMIDE

NIACIN/NIACINAMIDE (VITAMIN B-3)·NIACIN DEFICIENCY·+1
FREEDA VITAMINS

NIACINAMIDE

NIACIN/NIACINAMIDE (VITAMIN B-3)·NIACIN DEFICIENCY·+1
BASIC ORGANICS
Filter & compare in the drug finder →Opens the drug finder with Pellagra preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pellagra.

Pellagra is a systemic nutritional disorder caused by a severe cellular deficiency of niacin (vitamin B3) or its precursor amino acid, tryptophan, which impairs cellular metabolism and high-energy phosphate production.

Primarily affecting the cutaneous, gastrointestinal, and central nervous systems, it is observed in populations with inadequate dietary intake, chronic alcoholism, malabsorption disorders, or metabolic disruptions such as carcinoid syndrome or specific drug interactions.

Pathophysiologically, the condition is classically characterized by a triad often referred to as the "three Ds": photosensitive, symmetrical, hyperkeratotic dermatitis, persistent diarrhea, and neurocognitive impairment or encephalopathy, which can ultimately be fatal if left untreated.

Personalize your experience

Follow Pellagra and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it